Receipt: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020443 Read: 2026-11-12, curl of HTML page, tags stripped, HTTP 200 Note: Drugs@FDA record for GEREF (sermorelin acetate) NDA 020443: strength, Discontinued status, approval date. --- New Drug Application (NDA): 020443 Company: EMD SERONO INC Email Products on NDA 020443 Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS | GEREF | SERMORELIN ACETATE | EQ 0.5MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION | Discontinued | None | Yes | No | GEREF | SERMORELIN ACETATE | EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION | Discontinued | None | Yes | No | Approval Date(s) and History, Letters, Labels, Reviews for NDA 020443 Original Approvals or Tentative Approvals Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url | 09/26/1997 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD; Orphan | | Label is not available on this site. | |